With longer treatment duration, the BCR::ABL1 transcript quantity decreases gradually supporting the biological hypothesis of non-transcript producing quiescent CML cells also in pediatric CML patients43,44. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.